Clinical Trial

JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization

Study acronym: JAGUAR
Recruiting
View on ClinicalTrials.gov →
Summary
Prospective, randomized, multi-center study designed to evaluate the outcomes of commercially available contemporary EVAR in a real-world population. Patients will be randomized into two device cohorts and compared across the primary endpoints. Patients will be followed procedurally to discharge, at 1, 6, 12 months and annually through to 5 years (total follow-up commitment).
Protocol Amendment History 18 amendments
This ClinicalTrials.gov record has been amended 18 times since 2021-09-30; most recent amendment 2025-06-05.
Trial Details
NCT Number NCT05064540
Lead Sponsor Endologix
Conditions AAA, AAA - Abdominal Aortic Aneurysm
Enrollment 450 participants
Start Date 2021-09-20
Primary Completion 2031-03 (estimated)
Study Completion 2031-03 (estimated)
Updated on ClinicalTrials.gov 2025-06-08